Literature DB >> 2975199

A comparison of dapsone with 13-cis retinoic acid in the treatment of nodular cystic acne.

J S Prendiville, R A Logan, R Russell-Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2975199     DOI： 10.1111/j.1365-2230.1988.tb00659.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  7 in total

1.  Severe Nodulocystic Acne not Responding to Isotretinoin Therapy Successfully Treated with Oral Dapsone.

Authors:  Lutfi Al-Kathiri; Tasneem Al-Najjar
Journal:  Oman Med J       Date:  2018-09

2.  Drug usage evaluation of dapsone.

Authors:  G Kannan; J Vasantha; N Vanitha Rani; P Thennarasu; K Kousalya; P Anuradha; C Umamaheswara Reddy
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

3.  Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris.

Authors:  Diane M Thiboutot; Jonathan Willmer; Harry Sharata; Rebat Halder; Steven Garrett
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

4.  Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology.

Authors:  Ediléia Bagatin; Caroline Sousa Costa; Marco Alexandre Dias da Rocha; Fabíola Rosa Picosse; Cristhine Souza Leão Kamamoto; Rodrigo Pirmez; Mayra Ianhez; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2020-10-03       Impact factor: 1.896

5.  Oral isotretinoin for acne.

Authors:  Caroline S Costa; Ediléia Bagatin; Ana Luiza C Martimbianco; Edina Mk da Silva; Marília M Lúcio; Parker Magin; Rachel Riera
Journal:  Cochrane Database Syst Rev       Date:  2018-11-24

Review 6.  Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology.

Authors:  Swetalina Pradhan; Bhushan Madke; Poonam Kabra; Adarsh Lata Singh
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

Review 7.  Multitarget Approaches against Multiresistant Superbugs.

Authors:  Declan Alan Gray; Michaela Wenzel
Journal:  ACS Infect Dis       Date:  2020-03-19       Impact factor: 5.084
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.